Acute mucosal reactions in patients with head and neck cancer: Three patterns of mucositis observed during radiotherapy

Strahlentherapie und Onkologie

Volumn 189, Issue 7, 2013, Pages 547-551

  Wygoda, A ^a   Rutkowski, T ^a   Hutnik, M ^a   Skladowski K ^a   Golen M ^a   Pilecki, B ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Dose fractionation; Erythema; Healing; Mucositis; Toxicity

Indexed keywords

ACUTE MUCOSAL RADIATION REACTION; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; DYSPHAGIA; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MOUTH CANCER; MUCOSA INFLAMMATION; PHARYNX CANCER; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION SICKNESS;

ADULT; AGED; DISEASE PROGRESSION; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LARYNGEAL MUCOSA; MALE; MIDDLE AGED; MOUTH MUCOSA; MUCOSITIS; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PHARYNX; PROSPECTIVE STUDIES; RADIATION INJURIES;

EID: 84879973770     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0311-8     Document Type: Article

References (22)

1. Antognoni P, Bignardi M, Cazzaniga LF et al (1996) Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics-A phase II multicenter study. Int J Radiat Oncol Biol Phys 36(5):1137-1145 (Pubitemid 27014500)
2. Dische S (1994) The uniform reporting of treatment-related morbidity. Semin Radiat Oncol 4:112-118 (Pubitemid 24116949)
3. Fletcher GH, MacComb WS, Shalek RJ (1962) Radiation therapy in the management of cancer in the oral cavity and oropharynx. C.C. Thomas, Springfield, p 51
4. Fu KK, Pajak TF, Trotti A, Jones CU et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48(1):7-16 (Pubitemid 30488207)
5. Horiot JC, LeFurFR, Nguyen T et al (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231-241 (Pubitemid 23000765)
6. Kaanders JH, Van Daal WAJ, Hoogenraad WJ et al (1992) Accelerated fractionated radiotherapy for laryngeal cancer, acute and late toxicity. Int J Radiat Oncol Biol Phys 24:497-503
7. Kaanders JH, Van der Kogel AJ, Ang KK (1999) Altered fractionation: limited by mucosal reactions? Radiother Oncol 50:247-260 (Pubitemid 29207526)
8. Kubes J, Cvek J, Vondracek V et al (2011) Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks)-an alternative in the treatment of locally advanced head and neck cancer. Strahlenther Onkol 187:651-655
9. MacKenzie R, Balogh J, Choo R et al (1999) Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of head and neck. Int J Radiat Oncol Biol Phys 45(3):589-595 (Pubitemid 29462637)
10. Maciejewski B, Withers HR, Taylor JMG (1989) Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. I. Tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 16:831-843 (Pubitemid 19079722)
11. Maurer J, Hipp M, Schäfer C et al (2011) Dysphagia-Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol 187:744-749
12. O'Sullivan JM, Hollywood DP, Cody N et al (2002) Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer-A feasibility study. Clin Oncol 14(3):236-240
13. Overgaard J, Hansen HS, Specht et al (2003) Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362:933-940 (Pubitemid 37159288)
14. Quinn B, Potting CMJ, Stone R et al (2008) Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 44:61-72 (Pubitemid 350256936)
15. Semrau R, Temming S, Preuss SF et al (2011) Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel-A phase II study. Strahlenther Onkol 187:645-650
16. Skladowski K, Maciejewski B, Golen M et al (2006) Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial. Int J Radiat Oncol Biol Phys 66:706-713 (Pubitemid 44436685)
17. Sonis ST, Elting LS, Keefe D et al (2004) Perspectives on cancer therapy-induced mucosal injury. Cancer 100:1995-2025
18. Trotti A, Klotch D, Endicott J et al (1993) A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 26(1):181-182
19. Trotti A, Bellm LA, Epstein JB et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253-262 (Pubitemid 36556043)
20. Wolff HA, Bosch J, Jung K et al (2010) High-Grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 186:262-268
21. Wygoda A, Maciejewski B, Skladowski K et al (2009) Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation. Int J Radiat Oncol Biol Phys 73:384-390
22. Wygoda A, Skadowski K, Rutkowski T et al (2012) Acute mucosal radiation reactions in patients with head and neck cancer. Patterns of mucosal healing on the basis of daily examinations. Strahlenther Onkol 188:686-691